Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Huakang Medical Center appears to be a small private healthcare service entity in Beijing, China rather than a biotech, pharma, or life sciences product company. Public business-registry data indicates it was established in 2021 in Shunyi District, Beijing, and operates in the healthcare/services category. There is no credible evidence from available public sources that it runs a drug-development pipeline, proprietary therapeutic platform, or R&D programs typical of biotechnology companies. The requested name "Beijing Hua Kang Hospital" most likely refers imprecisely to this medical-center entity, but the exact hospital-name match could not be confirmed. It should therefore be classified primarily as a healthcare provider/medical service organization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Hua Kang Hospital.